June 25, 2021
1 min watch
Save
VIDEO: Presbyopia drug progresses through clinical trials
DENVER – Orasis Pharmaceutical President and COO Paul Smith told Healio here at Optometry’s Meeting that the company is proceeding from positive phase 2 study results to enrollment for a phase 3 protocol.
He said Orasis obtained funding that allowed them to initiate the NEAR-1 and NEAR-2 studies.